MedTrace Logo

Trial of Cognitive Behavioral Therapy for Schizophrenia

NCT00300651 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2006-03-09

No results posted yet for this study

Summary

The following study addresses the hypothesis that cognitive-behavioral interventions will be effective in reducing positive and negative symptoms of schizophrenia under the conditions of the German health care system. It is also hypothesized that interventions designed to reduce delusions will reduce cognitive biases and dysfunctional self-concepts.

Conditions

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy

Sponsors & Collaborators

  • Philipps University Marburg

    lead OTHER

Principal Investigators

  • Tania M Lincoln, PhD · Philipps-Universität Marburg, Faculty of Psychology, Section for Clinical Psychology and Psychotherapy

  • Tania M Lincoln, PhD · Philipps-Universität Marburg, Faculty of Psychology, Section for Clinical Psychology and Psychotherapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
16 Years
Max Age
69 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Completion
2009-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00300651 on ClinicalTrials.gov